Bilcare Limited

BSE:526853 Stock Report

Market Cap: ₹1.3b

Bilcare Past Earnings Performance

Past criteria checks 0/6

Bilcare has been growing earnings at an average annual rate of 50.3%, while the Life Sciences industry saw earnings growing at 25.3% annually. Revenues have been declining at an average rate of 21.5% per year.

Key information

50.3%

Earnings growth rate

50.3%

EPS growth rate

Life Sciences Industry Growth11.2%
Revenue growth rate-21.5%
Return on equity-13.0%
Net Margin-5.2%
Next Earnings Update14 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Bilcare makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:526853 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 247,709-4027760
30 Jun 247,591-3177110
31 Mar 247,472-3327460
31 Dec 237,8062396350
30 Sep 238,5151196540
30 Jun 239,1561386440
31 Mar 239,8161507360
31 Dec 2210,037-3706420
30 Sep 229,656-3216320
30 Jun 229,151-406190
31 Mar 228,447-1266190
31 Dec 217,648496070
30 Sep 217,135585890
30 Jun 216,617-2005770
31 Mar 216,227-2115710
31 Dec 205,6714386830
30 Sep 207,4329811,1270
30 Jun 2012,650-3252,4290
31 Mar 2018,270-1,0353,8680
31 Dec 1925,036-2,2985,4360
30 Sep 1928,970-3,8596,0730
30 Jun 1929,505-4,0846,1540
31 Mar 1929,970-4,5516,4700
31 Dec 1829,526-3,1536,4140
30 Sep 1829,325-3,2376,3120
30 Jun 1828,868-2,5515,7880
31 Mar 1827,784-2,0115,8630
31 Dec 1726,958-3,1495,6860
30 Sep 1726,234-2,2875,4870
30 Jun 1726,258-1,7675,2830
31 Mar 1726,329-8455,4920
31 Dec 1626,120-7355,6150
30 Sep 1626,264-5035,5600
30 Jun 1625,920-1405,4810
31 Mar 1626,029-8495,2880
31 Dec 1525,663-1,5218,2140
30 Sep 1525,818-1,6048,3050
30 Jun 1526,394-1,9065,2720
31 Mar 1526,923-1,7975,6800
31 Dec 1427,970-1,7748,8970
30 Sep 1427,719-1,4689,0820
30 Jun 1429,365-8295,7560
31 Mar 1430,620-1,1339,0110
31 Dec 1332,284-1,8228,9130

Quality Earnings: 526853 is currently unprofitable.

Growing Profit Margin: 526853 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 526853 is unprofitable, but has reduced losses over the past 5 years at a rate of 50.3% per year.

Accelerating Growth: Unable to compare 526853's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 526853 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (38.1%).

Return on Equity

High ROE: 526853 has a negative Return on Equity (-13%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 09:06
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bilcare Limited is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Ranjit KapadiaCentrum Broking Limited
Hemang TannaIndsec Securities & Finance Ltd.